Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025 June 6, 2025
Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025 May 12, 2025
Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025 April 25, 2025
Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology April 8, 2025
Rectify Pharma Presents Preclinical Data Supporting Development of Lead Candidate RTY-694 November 19, 2024
Rectify’s new lead candidate improves bile composition, reduces inflammation in mice with liver disease October 24, 2024
